Modulation of circulating endothelial progenitor cells by erythropoiesis-stimulating agents in patients with chronic kidney disease stage G5 and 5D 
.

CONCLUSION: We speculate that the pleiotropic effects of rhEPO and DA beyond their hematopoietic effects may differ between CKD G5 and 5D patients.
.
PMID: 27641052 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - September 18, 2016 Category: Urology & Nephrology Authors: Naito T, Sanaka T, Mikami H, Soga A, Yamatani K, Segawa K, Kawashima M, Yoshikura T, Niwayama J, Nishimura H, Ogawa T, Ando A, Teramoto A, Nitta K Tags: Clin Nephrol Source Type: research